The agonists of PPARγ have been widely applied for the management of hyperglycemia in T2DM by its effects on insulin sensitivity and serum adiponectin increase, and adipocyte differentiation induction that often results in weight gain [43, 44]. This evidence concerns the gene INS and Hyperglycemia.